Options Brief: Sangamo BioSciences

Shares of Sangamo BioSciences SGMO are lower on the session by 2.17%, trading at $4.97. Overall call volume is now running at 3.81x the daily average, with 86% of all calls traded being purchases on the offer. 1,279 contracts have traded on the session so far. Sangamo BioSciences, Inc. is engaged in the research, development and commercialization of zinc finger deoxyribonucleic acid (DNA)-binding proteins (ZFPs), a naturally occurring class of proteins, and develop a technology platform. ZFPs can be engineered to make ZFP transcription factors (ZFP TFs), proteins that can be used to turn genes on or off, and ZFP nucleases (ZFNs), proteins that enable it to modify DNA sequences in a range of ways.